https://www.selleckchem.com/pr....oducts/ITF2357(Givin
ups (area under the curve = 0.86 vs. 0.84, P = 0.76). There was no difference in rate of MACE between those with recent history of cancer in remission compared to their counterparts. A higher proportion of patients with cancer in remission was triaged as intermediate risk by the HEART score, but we found no difference in the performance of the HEART score between the groups. There was no difference in rate of MACE between those with recent history of cancer in remission compared to their counterparts. A higher proportion of
Like
Comment
Share
